In8Bio (INAB) Non-Current Assets (2020 - 2026)

In8Bio has disclosed Non-Current Assets across 7 years of filings, most recently posting $3.2 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 42.29% year-over-year to $3.2 million; the TTM figure through Jun 2026 stood at $3.2 million (down 42.29% YoY), while the FY2025 annual figure was $4.4 million, down 47.38% from the prior year.
• Non-Current Assets came in at $3.2 million for Q2 2026 at In8Bio, down from $3.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $10.8 million in Q4 2022 to a low of $3.2 million in Q2 2026.
• Average Non-Current Assets over 5 years is $7.2 million, with a median of $8.4 million recorded in 2024.
• Year-over-year, Non-Current Assets soared 233.18% in 2022 and plunged 49.57% in 2026.
• Over 5 years, Non-Current Assets stood at $10.8 million in 2022, then dropped by 15.93% to $9.1 million in 2023, then retreated by 7.9% to $8.4 million in 2024, then plunged by 47.38% to $4.4 million in 2025, then retreated by 26.19% to $3.2 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $3.2 million in Q2 2026, $3.6 million in Q1 2026, and $4.4 million in Q4 2025.